van Beers, Maartje A.
Speksnijder, Caroline M.
van Gils, Carla H.
Frederix, Geert W.J.
Dankbaar, Jan Willem
de Bree, Remco
Funding for this research was provided by:
KWF Kankerbestrijding (projectnumber: 12483)
Article History
Received: 13 December 2023
Accepted: 18 December 2023
First Online: 15 January 2024
Declarations
:
: This research project obtained ethical approval from the Medical Research Ethics Committee Utrecht (MERC 20–095) on May 1, 2020. Only patients who have willingly signed the informed consent will be eligible for enrollment in this study. Subsequent to receiving informed consent, each participating patient will be assigned a unique subject number, referred to as an allocation number. This allocated number will serve as the sole identifier for the patient throughout the course of the study and within the study’s database. All data pertaining to the enrolled patients, gathered during the study, will be securely stored under their respective allocation numbers.
: Not applicable.
: The authors declare that they have no competing interests.